tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFs
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

ROIV Stock Latest News

Optimistic Outlook for Roivant Sciences Driven by Promising Brepocitinib Results in Phase 3 VALOR Study
RatingsOptimistic Outlook for Roivant Sciences Driven by Promising Brepocitinib Results in Phase 3 VALOR Study
3d ago
ROIV
Roivant Sciences’ Growth Potential Highlighted by Upcoming Phase 3 VALOR Study for Brepocitinib
PremiumRatings
Roivant Sciences’ Growth Potential Highlighted by Upcoming Phase 3 VALOR Study for Brepocitinib
3d ago
ROIV
JPMorgan positive on Roivant into dermatomyositis readout
PremiumThe Fly
JPMorgan positive on Roivant into dermatomyositis readout
4d ago
ROIV
Roivant Sciences to hold an investor webinar
PremiumThe Fly
Roivant Sciences to hold an investor webinar
4d ago
ROIV
Sarepta suspends Elevidys shipments, Supernus acquires Sage: Morning Buzz
PremiumThe Fly
Sarepta suspends Elevidys shipments, Supernus acquires Sage: Morning Buzz
5d ago
BA
BMY
Pulmovant announces publication of PK, lung deposition data for mosliciguat
PremiumThe FlyPulmovant announces publication of PK, lung deposition data for mosliciguat
5d ago
ROIV
Strategic Growth and Orphan Drug Success Drive Buy Rating for Roivant Sciences
Premium
Ratings
Strategic Growth and Orphan Drug Success Drive Buy Rating for Roivant Sciences
18d ago
ROIV
Roivant Sciences Reports Progress and Financial Results
Premium
Company Announcements
Roivant Sciences Reports Progress and Financial Results
23d ago
ROIV
Roivant Sciences Earnings Call: Balancing Growth and Challenges
PremiumCompany Announcements
Roivant Sciences Earnings Call: Balancing Growth and Challenges
23d ago
ROIV
Roivant Sciences reports Q4 EPS (29c), consensus (16c)
PremiumThe Fly
Roivant Sciences reports Q4 EPS (29c), consensus (16c)
23d ago
ROIV
Roivant Sciences: Strategic Leadership and Promising Developments Drive Buy Rating
PremiumRatings
Roivant Sciences: Strategic Leadership and Promising Developments Drive Buy Rating
24d ago
ROIV
Is ROIV a Buy, Before Earnings?
PremiumPre-Earnings
Is ROIV a Buy, Before Earnings?
26d ago
ROIV
Strategic Leadership and Pipeline Advancements Drive Buy Rating for Roivant Sciences
PremiumRatingsStrategic Leadership and Pipeline Advancements Drive Buy Rating for Roivant Sciences
2M ago
ROIV
Strategic Advancements and Growth Potential Justify Buy Rating for Roivant Sciences
Premium
Ratings
Strategic Advancements and Growth Potential Justify Buy Rating for Roivant Sciences
2M ago
ROIV
Roivant Sciences Announces Leadership Changes at Immunovant
Premium
Company Announcements
Roivant Sciences Announces Leadership Changes at Immunovant
2M ago
8K
ROIV
Immunovant appoints Eric Venker as CEO, Girao as CFO
PremiumThe Fly
Immunovant appoints Eric Venker as CEO, Girao as CFO
2M ago
IMVT
ROIV
Promising Potential of Roivant Sciences: Buy Rating for FcRn Inhibitor Advancements
PremiumRatings
Promising Potential of Roivant Sciences: Buy Rating for FcRn Inhibitor Advancements
3M ago
ROIV
Roivant Sciences Engages Former Officer for Advisory Role
PremiumCompany Announcements
Roivant Sciences Engages Former Officer for Advisory Role
3M ago
8K
ROIV
Roivant Sciences Announces Positive Results for Batoclimab Studies
PremiumCompany Announcements
Roivant Sciences Announces Positive Results for Batoclimab Studies
3M ago
8K
ROIV
Roivant says Immunovant announces results from Phase 3 study of batoclimab in MG
PremiumThe FlyRoivant says Immunovant announces results from Phase 3 study of batoclimab in MG
3M ago
IMVT
ROIV
Strategic Growth Potential in Roivant Sciences: Capitalizing on Graves’ Disease Market and FcRn Indications
Premium
Ratings
Strategic Growth Potential in Roivant Sciences: Capitalizing on Graves’ Disease Market and FcRn Indications
3M ago
ROIV
Genevant, Arbutus initiate patent infringement actions against Moderna
Premium
The Fly
Genevant, Arbutus initiate patent infringement actions against Moderna
4M ago
ABUS
MRNA

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >